OMV Closes the Borouge International Deal Just as the Strait of Hormuz Shuts
A game-changing chemicals merger coincides with a Middle East shock, exposing OMV to both turbulence and opportunity.
OMV.VI · Earnings Call · 2026-05-02
A quarter of two seismic shifts
For OMV, Q1 2026 will be remembered as the quarter when two colossal forces converged: the long-planned creation of Borouge International and the abrupt closure of the Strait of Hormuz. The first is a strategic masterstroke that repositions the company's entire chemicals franchise; the second is an unforeseen shock that has upended global energy flows and, in the process, created both headwinds and tailwinds for OMV's integrated model. The company delivered a solid albeit softer clean operating result of €1.0 billion (down 12% year-on-year) and, more importantly, operating cash flow before working capital of €1.6 billion — substantially higher than both the prior quarter and prior year, despite the chaos. As CFO Reinhard Florey noted, “the impact of the Borouge International transaction on our leverage ratio was fairly limited. It rose from 14% to 17% at the end of the first quarter.” — Reinhard Florey, CFO · 2026-05-02 That leverage remains well below the 30% threshold, giving OMV flexibility to navigate the volatile environment.The strategic pivot: Borouge International
On March 31, OMV and ADNOC's investment arm XRG completed the creation of Borouge International, combining Borealis, Borouge and NOVA Chemicals to form the world's fourth-largest polyolefin producer. OMV injected €1.5 billion to equalize ownership at 50-50. The deal had been in the works for over a year — in February 2025 CEO Alfred Stern described it as 'ongoing and open-ended negotiation' (“We are in ongoing and open-ended negotiation and will require that we find an agreement also with ADNOC.” — Alfred Stern, CEO · 2025-02-08) — and its completion marks a decisive turning point for OMV's strategy. In November 2025, CFO Reinhard Florey reiterated the post-close leverage target: “We want to reaffirm by that statement that we stay in the low 20s percentage, which should be really an affirmation of our statement of low leverage, including also the transaction of BGI.” — Reinhard Florey, Chief Financial Officer (CFO) · 2026-02-04 The new entity is expected to deliver pro forma EBITDA of more than $7 billion through the cycle, up from an average of $4.5 billion. Crucially, Borouge International has demonstrated structural pricing power: over the past five years it has consistently achieved price premiums of almost 20% against market benchmarks, even at the bottom of the cycle. As Alfred Stern proudly put it,This profitability is underpinned by operational excellence — utilization rates near 90%, versus an industry average of just over 80% — and an advantaged feedstock position.Between 2021 and 2025, Borouge International proved to be the most profitable player through the cycle. And even at the bottom of the cycle, the margin profile were comparable with the very best in the specialty chemicals industry.